Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography
暂无分享,去创建一个
S. Plein | S. Petersen | J. Grapsa | M. Dweck | P. Erba | T. Edvardsen | D. Neglia | C. Tribouilloy | K. Klingel | B. Popescu | M. Galderisi | E. Donal | G. Derumeaux | R. Slart | P. Lancellotti | A. Jacquier | P. Charron | G. Habib | B. Cosyns | K. Haugaa | L. Sade | V. Delgado | A. Caforio | O. Gaemperli | A. Pepe | P. Réant | N. Cardim | J. Zamorano | C. Bucciarelli-Ducci | L. Ernande | E. Salaun | P. Perrone-filardi | G. Vijayaraghavan | A. Caforio | A. Dehaene | Steffen E. Petersen
[1] Amjad M Ahmed,et al. Multimodality Imaging of Pericardial Diseases , 2017, Current Treatment Options in Cardiovascular Medicine.
[2] V. Fuster,et al. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease. , 2017, JACC. Cardiovascular imaging.
[3] U. Landmesser,et al. Restrictive cardiomyopathy , 2017, Wiener klinische Wochenschrift.
[4] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[5] D. Pennell,et al. Comparison of 3 T and 1.5 T for T2* magnetic resonance of tissue iron , 2016, Journal of Cardiovascular Magnetic Resonance.
[6] L. Emmett,et al. Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis , 2016, Clinical nuclear medicine.
[7] James C Moon,et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis , 2016, Circulation.
[8] D. Mele,et al. Longitudinal strain of left ventricular basal segments and E/e′ ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study , 2016, Echocardiography.
[9] B. Maciel,et al. A Challenging Differential Diagnosis: Distinguishing between Endomyocardial Fibrosis and Apical Hypertrophic Cardiomyopathy , 2016, Echocardiography.
[10] E. Braunlin,et al. Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs , 2016, Heart.
[11] J. Deux,et al. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. , 2016, JACC Cardiovascular Imaging.
[12] M. Nishimura,et al. F-fluorodeoxyglucose Positron Emission Tomography (fdg Pet) and Cardiac Magnetic Resonance (cmr) in Corticosteroid-naive Patients with Conduction System Disease Due to Cardiac Sarcoidosis , 2022 .
[13] P. Kellman,et al. Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage , 2015, Journal of the American Heart Association.
[14] Jeroen J. Bax,et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases , 2015, European heart journal.
[15] P. Kellman,et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2015, Circulation.
[16] C. Tribouilloy,et al. Sub-aortic obstruction of left ventricular outflow tract secondary to benfluorex-induced endocardial fibrosis , 2015, International journal of cardiology. Heart & vasculature.
[17] M. Miyagawa,et al. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis. , 2015, International journal of cardiology.
[18] I. Dato. How to recognize endomyocardial fibrosis? , 2015, Journal of cardiovascular medicine.
[19] V. Positano,et al. Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study , 2015, Circulation. Cardiovascular imaging.
[20] E. Fosse,et al. Myocardial Function by Two-Dimensional Speckle Tracking Echocardiography and Activin A May Predict Mortality in Patients with Carcinoid Intestinal Disease , 2015, Cardiology.
[21] M. Galderisi,et al. Left Ventricular Diastolic Dysfunction in Type I Gaucher Disease: An Echo Doppler Study , 2015, Echocardiography.
[22] A. Voskoboinik,et al. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. , 2015, European heart journal cardiovascular Imaging.
[23] J. Moon,et al. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study. , 2015, Radiology.
[24] U. Kramer,et al. Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial Biopsy , 2015, PloS one.
[25] M. Montaudon,et al. Eosinophilic cardiac disease: Molecular, clinical and imaging aspects. , 2015, Archives of cardiovascular diseases.
[26] J. Koyama,et al. Echocardiographic assessment of the cardiac amyloidoses. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[27] F. Salvi,et al. Cardiac amyloidosis: the great pretender , 2015, Heart Failure Reviews.
[28] Erwan Donal,et al. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. , 2015, European heart journal cardiovascular Imaging.
[29] V. Positano,et al. Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy. , 2015, European heart journal cardiovascular Imaging.
[30] J. Airaksinen,et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. , 2015, Circulation.
[31] A. Jacquier,et al. Cardiac involvement in hypereosinophilic syndrome: role of multimodality imaging. , 2015, European heart journal cardiovascular Imaging.
[32] M. Maurer,et al. The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis , 2015, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[33] S. Achenbach,et al. European Association of Cardiovascular Imaging (EACVI) position paper: Multimodality imaging in pericardial disease. , 2014, European heart journal cardiovascular Imaging.
[34] A. Kharabish,et al. Cardiac MRI findings of endomyocardial fibrosis (Loeffler’s endocarditis) in a patient with rheumatoid arthritis , 2014, Journal of the Saudi Heart Association.
[35] P. Charron,et al. The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) , 2015 .
[36] M. Cerinic,et al. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. , 2015, European heart journal cardiovascular Imaging.
[37] P. Hawkins,et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. , 2014, European heart journal cardiovascular Imaging.
[38] F. Rutten,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.
[39] M. Cerqueira,et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2014, European heart journal cardiovascular Imaging.
[40] G. Feuchtner,et al. Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: multidetector computed tomography versus magnetic resonance imaging. , 2014, European journal of radiology.
[41] S. Nagueh. Anderson-Fabry Disease and Other Lysosomal Storage Disorders , 2014, Circulation.
[42] B. Khandheria,et al. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. , 2014, European heart journal cardiovascular Imaging.
[43] L. Mestroni,et al. Danon Disease: Clinical Features, Evaluation, and Management , 2014, Circulation. Heart failure.
[44] G. Pedrizzetti,et al. Diagnostic Concordance of Echocardiography and Cardiac Magnetic Resonance–Based Tissue Tracking for Differentiating Constrictive Pericarditis From Restrictive Cardiomyopathy , 2014, Circulation. Cardiovascular imaging.
[45] Amit R. Patel,et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.
[46] A. Prasse,et al. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. , 2014, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[47] D. Burstow,et al. Non-tropical endomyocardial fibrosis associated with sarcoidosis. , 2014, European heart journal cardiovascular Imaging.
[48] H. Wiste,et al. Echocardiographic Diagnosis of Constrictive Pericarditis: Mayo Clinic Criteria , 2014, Circulation Cardiovascular Imaging.
[49] B. Hazenberg,et al. Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[50] S. Solomon,et al. Left Ventricular Structure and Function in Transthyretin-Related Versus Light-Chain Cardiac Amyloidosis , 2014, Circulation.
[51] P. Croisille,et al. Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. , 2014, Radiology.
[52] Jon Hainer,et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. , 2012, Journal of the American College of Cardiology.
[53] R. Falk,et al. Left Ventricular Structure and Function in TTR-Related versus AL Cardiac Amyloidosis , 2014 .
[54] E. Fleck,et al. Endomyocardial fibrosis in patients with confirmed Churg-Strauss syndrome. , 2014, Rheumatology.
[55] M. Cerqueira,et al. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: State of the art review and focus on emerging nuclear techniques , 2014, Journal of Nuclear Cardiology.
[56] R. Blankstein,et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis , 2014, Journal of Nuclear Cardiology.
[57] P. Segers,et al. Characterization of Cardiovascular Involvement in Pseudoxanthoma Elasticum Families , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[58] Scott D Flamm,et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update , 2013, Journal of Cardiovascular Magnetic Resonance.
[59] S. Wann,et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[60] S. Punwani,et al. Measurement of Tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging. , 2013, Radiology.
[61] D. Pennell,et al. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. , 2013, Circulation.
[62] M. de Carvalho,et al. Reduced Myocardial 123-Iodine Metaiodobenzylguanidine Uptake: A Prognostic Marker in Familial Amyloid Polyneuropathy , 2013, Circulation. Cardiovascular imaging.
[63] M. Hamilton,et al. Diagnosing cardiac involvement in the hypereosinophilic syndrome by cardiac magnetic resonance. , 2013, The American journal of cardiology.
[64] Y. Pinto,et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[65] S. Flamm,et al. Biventricular Mechanics in Constrictive Pericarditis Comparison With Restrictive Cardiomyopathy and Impact of Pericardiectomy , 2013, Circulation. Cardiovascular imaging.
[66] S. K. White,et al. Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.
[67] X. M. Liu,et al. A study of glycogen storage disease with 99Tcm-MIBI gated myocardial perfusion imaging , 2013, Irish Journal of Medical Science.
[68] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[69] Allison R. Schulman,et al. 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis , 2013, Current cardiology reports.
[70] M. Maurer,et al. 99mTc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses , 2013, Circulation. Cardiovascular imaging.
[71] A. Mazzeo,et al. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. , 2013, AJR. American journal of roentgenology.
[72] A. Flett,et al. Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.
[73] Allison R. Schulman,et al. 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis , 2013, Current Cardiology Reports.
[74] S. Wann,et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2013, European heart journal cardiovascular Imaging.
[75] A. Halkin,et al. Hypereosinophilic syndrome with cardiac involvement: early diagnosis by cardiac magnetic resonance imaging. , 2012, The Canadian journal of cardiology.
[76] M. Yacoub,et al. Patterns of Disease Progression in Hypertrophic Cardiomyopathy: An Individualized Approach to Clinical Staging , 2012, Circulation. Heart failure.
[77] A. Mocumbi. Endomyocardial fibrosis: A form of endemic restrictive cardiomyopathy , 2012, Global cardiology science & practice.
[78] James D. Thomas,et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis , 2012, Heart.
[79] P. Kellman,et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.
[80] A. Proclemer,et al. Cardiac Magnetic Resonance Imaging in Danon Disease , 2012, Cardiology.
[81] Robert A. deKemp,et al. The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience , 2012, The Journal of Nuclear Medicine.
[82] K. Hermans,et al. Carcinoid heart disease: typical findings on echocardiography and cardiac magnetic resonance. , 2012, Acta cardiologica.
[83] Jeroen J. Bax,et al. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias. , 2011, Arthritis and rheumatism.
[84] G. Youssef,et al. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment , 2011, Heart.
[85] Bryan L Roth,et al. Serotonin receptors and heart valve disease--it was meant 2B. , 2011, Pharmacology & therapeutics.
[86] Titus Kuehne,et al. Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping , 2011, Circulation. Cardiovascular imaging.
[87] L. Pérez de Isla,et al. Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[88] T. Edvardsen,et al. Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[89] F. Salvi,et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. , 2011, JACC. Cardiovascular imaging.
[90] A. Leask. The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis. , 2011, Pharmacological research.
[91] Matthew R. G. Taylor,et al. Natural history of Danon disease , 2011, Genetics in Medicine.
[92] L. Tick,et al. Cardiac involvement in hypereosinophilic syndrome. , 2011, The Netherlands journal of medicine.
[93] Raymond J Kim,et al. Late Gadolinium Enhancement Magnetic Resonance Imaging in the Diagnosis and Prognosis of Endomyocardial Fibrosis Patients , 2011, Circulation. Cardiovascular imaging.
[94] S. Achenbach,et al. Myocardial viability by dual-energy delayed enhancement computed tomography. , 2011, JACC. Cardiovascular imaging.
[95] A. Cohen-Solal,et al. Isolated left ventricular non‐compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry , 2011, European journal of heart failure.
[96] R. D. du Bois,et al. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[97] Massimo Midiri,et al. Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging , 2011, Haematologica.
[98] J. Stockman. Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy , 2011 .
[99] M. Yacoub,et al. Echocardiography accurately assesses the pathological abnormalities of chronic endomyocardial fibrosis , 2011, The International Journal of Cardiovascular Imaging.
[100] R. Kim,et al. Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. , 2010, Molecular genetics and metabolism.
[101] L. Tavazzi,et al. When should cardiologists suspect Anderson-Fabry disease? , 2010, The American journal of cardiology.
[102] M. Fielden,et al. Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans. , 2010, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[103] J. Saban-Ruiz,et al. Pseudoxanthoma elasticum: case report with arterial stiffness evaluated by a research cardiovascular profiling system. , 2010, European journal of dermatology : EJD.
[104] W. Manning,et al. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.
[105] E. Feierl,et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database , 2010, Annals of the rheumatic diseases.
[106] Richard D. White,et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.
[107] Manesh R. Patel,et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.
[108] T. Abraham,et al. Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[109] A. Angelini,et al. Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy , 2010, European heart journal.
[110] F. Weidemann,et al. Cardiac challenges in patients with Fabry disease. , 2010, International journal of cardiology.
[111] C. Higgins,et al. Hypertrophic cardiomyopathy with restrictive phenotype and myocardial crypts. , 2010, Journal of thoracic imaging.
[112] A. Keren,et al. &bgr;-Thalassemia Cardiomyopathy: History, Present Considerations, and Future Perspectives , 2010, Circulation. Heart failure.
[113] A. Fayssoil. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.
[114] J. Seward,et al. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. , 2010, Journal of the American College of Cardiology.
[115] Matthew W. Martinez,et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.
[116] D. Farge,et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis , 2009, Annals of the rheumatic diseases.
[117] G. Boriani,et al. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.
[118] R. Kim,et al. Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.
[119] V. Positano,et al. Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major , 2009, Heart.
[120] R. Schiffmann,et al. Agalsidase alfa and kidney dysfunction in Fabry disease. , 2009, Journal of the American Society of Nephrology : JASN.
[121] A. Del Maschio,et al. Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. , 2009, AJR. American journal of roentgenology.
[122] J. Zamorano,et al. Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy. , 2009, International journal of cardiology.
[123] N. Lamblin,et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients , 2008, Annals of the rheumatic diseases.
[124] F. Flachskampf,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[125] S. Feriozzi,et al. Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease , 2008, American Journal of Nephrology.
[126] Matthew W. Darlison,et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[127] M. Yacoub,et al. A population study of endomyocardial fibrosis in a rural area of Mozambique. , 2008, The New England journal of medicine.
[128] L. Mouthon,et al. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. , 2008, Arthritis and rheumatism.
[129] P. Cianciulli,et al. Guideline recommendations for heart complications in thalassemia major , 2008, Journal of cardiovascular medicine.
[130] K. Klingel,et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.
[131] G. Bukhman,et al. Endomyocardial Fibrosis: Still a Mystery after 60 Years , 2008, PLoS neglected tropical diseases.
[132] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[133] J. Seward,et al. Disparate patterns of left ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. , 2008, JACC. Cardiovascular imaging.
[134] M. Nishimura,et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[135] Krishnaswamy Chandrasekaran,et al. Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis , 2007, Circulation.
[136] E. Gotsis,et al. Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion dependent thalassemia major (TM) , 2007, Cardiovascular ultrasound.
[137] J. Zamorano,et al. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. , 2007, European heart journal.
[138] A. Ignaszewski,et al. Eosinophilic myocarditis: case series and review of literature. , 2006, The Canadian journal of cardiology.
[139] B. Maron,et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). , 2006, The American journal of cardiology.
[140] M. Galderisi,et al. Detection of increased left ventricular filling pressure by pulsed tissue Doppler in cardiac amyloidosis , 2006, Journal of cardiovascular medicine.
[141] F. Duru,et al. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. , 2006, International journal of cardiology.
[142] G. Giannakoulas,et al. Survival in thalassaemia major patients. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[143] C. Rapezzi,et al. Isolated ventricular non-compaction with restrictive cardiomyopathy. , 2006, European heart journal.
[144] L. Nguyen,et al. Left ventricular systolic and diastolic function by echocardiogram in pseudoxanthoma elasticum. , 2006, The American journal of cardiology.
[145] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[146] M. Friedrich,et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance , 2005, Heart.
[147] A. Moss,et al. Contemporary Definitions and Classification of the Cardiomyopathies , 2006 .
[148] Marco Francone,et al. Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy , 2006, European Radiology.
[149] M. Scherillo,et al. Early impairment of myocardial function in systemic sclerosis: non-invasive assessment by Doppler myocardial and strain rate imaging. , 2005, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[150] F. Salvi,et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. , 2005, Journal of the American College of Cardiology.
[151] Lawrence B Marks,et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. , 2005, International journal of radiation oncology, biology, physics.
[152] M. Nishimura,et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. , 2005, European heart journal.
[153] I. Palacios,et al. Visualization of Endomyocardial Fibrosis by Delayed-Enhancement Magnetic Resonance Imaging , 2005 .
[154] R. Falk,et al. Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.
[155] Mark Kidd,et al. Carcinoid Tumors and Fibrosis: An Association with No Explanation , 2004, The American Journal of Gastroenterology.
[156] T. Yokoyama,et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of Nuclear Medicine.
[157] M. Yoshiyama,et al. Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation , 2004, Heart.
[158] M. Russo,et al. Tissue Doppler imaging in Fabry disease , 2004, Current opinion in cardiology.
[159] J. Seward,et al. Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. , 2004, The American journal of cardiology.
[160] P. Sengupta,et al. Accuracy and pitfalls of early diastolic motion of the mitral annulus for diagnosing constrictive pericarditis by tissue Doppler imaging. , 2004, The American journal of cardiology.
[161] C. Mecucci,et al. Rapid Reversion of Loeffler's Endocarditis by Imatinib in Early Stage Clonal Hypereosinophilic Syndrome , 2004, Leukemia & lymphoma.
[162] K. Macdermot,et al. Natural history of Fabry disease in affected males and obligate carrier females , 2001, Journal of Inherited Metabolic Disease.
[163] A. Tajik,et al. Constrictive Pericarditis in 26 Patients With Histologically Normal Pericardial Thickness , 2003, Circulation.
[164] N. Messaddeq,et al. Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5‐HT2B‐receptor signaling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[165] M. Yoshiyama,et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[166] G. Bosi,et al. Left ventricular remodelling, and systolic and diastolic function in young adults with β thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data , 2003, Heart.
[167] Tracy L Faber,et al. Multimodality imaging. , 2003, Seminars in nuclear medicine.
[168] A. Tajik,et al. Diagnostic value of mitral annular velocity for constrictive pericarditis in the absence of respiratory variation in mitral inflow velocity. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[169] R. Dietz,et al. Fabry Disease: Focus on Cardiac Manifestations and Molecular Mechanisms , 2002, Herz.
[170] J. Tam,et al. Echocardiographic assessment of patients with hypertrophic and restrictive cardiomyopathy: imaging and echocardiography , 2002, Current opinion in cardiology.
[171] S. Nakatani,et al. Echocardiographic Manifestations in Patients with Cardiac Sarcoidosis , 2002 .
[172] D N Firmin,et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.
[173] Hancock Ew. Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis , 2001 .
[174] E. W. Hancock. Di V erential diagnosis of restrictive cardiomyopathy and constrictive pericarditis , 2001 .
[175] F. Joshua,et al. Idiopathic Hypereosinophilic Syndrome: Magnetic Resonance Imaging Findings in Endomyocardial Fibrosis , 2001, Australasian radiology.
[176] D. Burstow,et al. Transesophageal echocardiographic abnormalities in a case of cardiac sarcoidosis. , 2001, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[177] R. D. Murray,et al. Comparison of new Doppler echocardiographic methods to differentiate constrictive pericardial heart disease and restrictive cardiomyopathy. , 2001, The American journal of cardiology.
[178] H. Torp,et al. Myocardial Strain by Doppler Echocardiography: Validation of a New Method to Quantify Regional Myocardial Function , 2000, Circulation.
[179] J. Seward,et al. Clinical and echocardiographic features of hypereosinophilic syndromes. , 2000, The American journal of cardiology.
[180] D J Pennell,et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[181] B. Maron,et al. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.
[182] T. Cloward,et al. Endocardial fibrosis associated with fenfluramine-phentermine. , 1998, The New England journal of medicine.
[183] E. Arbustini,et al. Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. , 1998, Journal of the American College of Cardiology.
[184] L. Constine,et al. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. , 1997, International journal of radiation oncology, biology, physics.
[185] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[186] J. Seward,et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. , 1993, Circulation.
[187] P. Vaitkus,et al. Constrictive pericarditis versus restrictive cardiomyopathy: a reappraisal and update of diagnostic criteria. , 1991, American heart journal.
[188] J. Seward,et al. Prognostic Significance of Doppler Measures of Diastolic Function in Cardiac Amyloidosis: A Doppler Echocardiography Study , 1991, Circulation.
[189] Miller Tr,et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). , 1990, The Journal of rheumatology.
[190] R. Shabetai. Pathophysiology and differential diagnosis of restrictive cardiomyopathy. , 1988, Cardiovascular clinics.
[191] I. Markhasina. [Echocardiographic diagnosis of constrictive pericarditis]. , 1985, Terapevticheskii arkhiv.
[192] T. Medsger,et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. , 1984, The New England journal of medicine.
[193] E. Arbustini,et al. Cardiac ultrastructure in primary restrictive cardiomyopathy. , 1983, Chest.
[194] N. Schiller,et al. Value of Two–dimensional Echocardiography in Endomyocardial Disease With and Without Eosinophilia: A Clinical and Pathologic Study , 1983, Circulation.
[195] N C Nanda,et al. Myocardial texture characterization by two-dimensional echocardiography. , 1983, The American journal of cardiology.
[196] W. Kleijer,et al. Echocardiographic features in the cardiac type of glycogen storage disease II. , 1983, European heart journal.
[197] F. Maritz,et al. Pseudoxanthoma elasticum with cardiac involvement. A case report and review of the literature. , 1981, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[198] A. Nienhuis,et al. Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload. , 1979, The New England journal of medicine.
[199] W. Engel,et al. SCANNING FOR SOFT-TISSUE AMYLOID , 1977, The Lancet.
[200] R. Solinger,et al. Echocardiographic evidence of outflow tract obstruction in Pompe's disease (glycogen storage disease of the heart). , 1976, The American journal of cardiology.
[201] E. Keat,et al. Carcinoid Heart Disease , 1974, Proceedings of the Royal Society of Medicine.
[202] Gershwin Me,et al. Letter: Loss of suppressor function as a cause of lymphoid malignancy. , 1974 .
[203] J. Bonner,et al. Differentiation , 1968, Nature.
[204] R. Musgrave,et al. Long-term outcome and patterns of failure in patients with advanced head and neck cancer , 2011, Radiation oncology.